TreeWAS – Variant ID: rs6923811

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E83.1 Disorders of iron metabolism	0.000	0.000	1.000
K90.0 Coeliac disease	1.000	0.000	0.000
K90 Intestinal malabsorption	0.389	0.611	0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified	0.345	0.655	0.000
E83 Disorders of mineral metabolism	0.000	0.685	0.315
E83.3 Disorders of phosphorus metabolism	0.000	0.719	0.281
K90.3 Pancreatic steatorrhoea	0.279	0.721	0.000
K90.2 Blind loop syndrome, not elsewhere classified	0.279	0.721	0.000
K90.1 Tropical sprue	0.279	0.721	0.000
K90.9 Intestinal malabsorption, unspecified	0.227	0.773	0.000
E83.9 Disorder of mineral metabolism, unspecified	0.000	0.774	0.226
E83.8 Other disorders of mineral metabolism	0.000	0.774	0.226
E83.2 Disorders of zinc metabolism	0.000	0.774	0.226
E83.0 Disorders of copper metabolism	0.000	0.774	0.226
E83.4 Disorders of magnesium metabolism	0.000	0.792	0.208
K90.8 Other intestinal malabsorption	0.161	0.838	0.001
T39.1 4-Aminophenol derivatives	0.000	0.897	0.103
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.906	0.094
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.909	0.091
T42.4 Benzodiazepines	0.000	0.910	0.090
T39.0 Salicylates	0.000	0.911	0.089
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.914	0.086
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.917	0.083
T42.0 Hydantoin derivatives	0.000	0.920	0.080
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.926	0.074
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.929	0.071
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.929	0.071
T39.4 Antirheumatics, not elsewhere classified	0.000	0.932	0.067
T39.2 Pyrazolone derivatives	0.000	0.932	0.067
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.935	0.065
T42.2 Succinimides and oxazolidinediones	0.000	0.935	0.065
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.936	0.064
T42.1 Iminostilbenes	0.000	0.937	0.063
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.937	0.063
T36 Poisoning by systemic antibiotics	0.000	0.938	0.062
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.939	0.061
T40.4 Other synthetic narcotics	0.000	0.940	0.060
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.941	0.059
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.941	0.059
T40.2 Other opioids	0.000	0.942	0.058
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.942	0.058
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.943	0.057
T42.3 Barbiturates	0.000	0.943	0.056
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.945	0.055
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.945	0.055
T40.6 Other and unspecified narcotics	0.000	0.947	0.053
N40 Hyperplasia of prostate	0.000	0.948	0.052
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.949	0.051
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.949	0.051
T40.8 Lysergide [LSD]	0.000	0.949	0.051
T40.7 Cannabis (derivatives)	0.000	0.949	0.051
T40.3 Methadone	0.000	0.949	0.051
T40.0 Opium	0.000	0.949	0.051
T50.4 Drugs affecting uric acid metabolism	0.000	0.950	0.050
T40.5 Cocaine	0.000	0.951	0.049
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.952	0.048
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.952	0.048
C91.1 Chronic lymphocytic leukaemia	0.048	0.952	0.000
T45.2 Vitamins, not elsewhere classified	0.000	0.953	0.047
T36.0 Penicillins	0.000	0.953	0.047
T50.8 Diagnostic agents	0.000	0.954	0.046
T50.7 Analeptics and opioid receptor antagonists	0.000	0.954	0.046
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.954	0.046
T50.5 Appetite depressants	0.000	0.954	0.046
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.954	0.046
T50.1 Loop [high-ceiling] diuretics	0.000	0.954	0.046
T50.0 Mineralocorticoids and their antagonists	0.000	0.954	0.046
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.955	0.045
T37.5 Antiviral drugs	0.000	0.955	0.045
T37.4 Anthelminthics	0.000	0.955	0.045
T37.3 Other antiprotozoal drugs	0.000	0.955	0.045
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.955	0.045
T37.1 Antimycobacterial drugs	0.000	0.955	0.045
T37.0 Sulphonamides	0.000	0.955	0.045
T36.3 Macrolides	0.000	0.955	0.045
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.955	0.045
T36.9 Systemic antibiotic, unspecified	0.000	0.955	0.044
T36.8 Other systemic antibiotics	0.000	0.955	0.044
T36.7 Antifungal antibiotics, systemically used	0.000	0.955	0.044
T36.6 Rifamycins	0.000	0.955	0.044
T36.5 Aminoglycosides	0.000	0.955	0.044
T36.4 Tetracyclines	0.000	0.955	0.044
T36.2 Chloramphenicol group	0.000	0.955	0.044
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.955	0.044
T40.1 Heroin	0.000	0.956	0.044
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.956	0.044
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.956	0.044
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.956	0.044
T45.5 Anticoagulants	0.000	0.956	0.044
T41.5 Therapeutic gases	0.000	0.957	0.043
T41.4 Anaesthetic, unspecified	0.000	0.957	0.043
T41.3 Local anaesthetics	0.000	0.957	0.043
T41.2 Other and unspecified general anaesthetics	0.000	0.957	0.043
T41.1 Intravenous anaesthetics	0.000	0.957	0.043
T41.0 Inhaled anaesthetics	0.000	0.957	0.043
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.957	0.042
T45.8 Other primarily systemic and haematological agents	0.000	0.957	0.042
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.957	0.042
T45.6 Fibrinolysis-affecting drugs	0.000	0.957	0.042
T45.4 Iron and its compounds	0.000	0.957	0.042
T45.3 Enzymes, not elsewhere classified	0.000	0.957	0.042
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.958	0.042
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.958	0.042
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.958	0.042
C91 Lymphoid leukaemia	0.042	0.958	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.958	0.042
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.958	0.042
T46.7 Peripheral vasodilators	0.000	0.958	0.042
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.958	0.042
C84 Peripheral and cutaneous T-cell lymphomas	0.041	0.959	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.959	0.041
T48.4 Expectorants	0.000	0.959	0.041
T48.3 Antitussives	0.000	0.959	0.041
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.959	0.041
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.959	0.041
T48.0 Oxytocic drugs	0.000	0.959	0.041
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.959	0.041
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.960	0.040
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.040	0.960	0.000
T49.9 Topical agent, unspecified	0.000	0.960	0.040
T49.8 Other topical agents	0.000	0.960	0.040
T49.7 Dental drugs, topically applied	0.000	0.960	0.040
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.960	0.040
T49.5 Ophthalmological drugs and preparations	0.000	0.960	0.040
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.960	0.040
T49.3 Emollients, demulcents and protectants	0.000	0.960	0.040
T49.2 Local astringents and local detergents	0.000	0.960	0.040
T49.1 Antipruritics	0.000	0.960	0.040
C84.5 Other and unspecified T-cell lymphomas	0.038	0.962	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.962	0.037
C84.0 Mycosis fungoides	0.037	0.963	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.963	0.037
T48.5 Anti-common-cold drugs	0.000	0.963	0.036
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.964	0.035
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.966	0.034
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.966	0.034
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.966	0.034
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.966	0.034
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.966	0.034
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.966	0.034
T44.0 Anticholinesterase agents	0.000	0.966	0.034
O82.0 Delivery by elective Caesarean section	0.000	0.966	0.034
C84.8 Cutaneous T-cell lymphoma, unspecified	0.034	0.966	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.034	0.966	0.000
C84.4 Peripheral T-cell lymphoma	0.033	0.967	0.000
T46.1 Calcium-channel blockers	0.000	0.967	0.033
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.967	0.033
C95 Leukaemia of unspecified cell type	0.032	0.968	0.000
K90-K93 Other diseases of the digestive system	0.032	0.968	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.968	0.032
C83 Diffuse non-Hodgkin's lymphoma	0.032	0.968	0.000
C86 Other specified types of T/NK-cell lymphoma	0.031	0.969	0.000
C88 Malignant immunoproliferative diseases	0.031	0.969	0.000
C91.5 Adult T-cell leukaemia	0.031	0.969	0.000
C91.9 Lymphoid leukaemia, unspecified	0.030	0.969	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.970	0.030
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.970	0.030
T38.7 Androgens and anabolic congeners	0.000	0.970	0.030
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.970	0.030
T38.5 Other oestrogens and progestogens	0.000	0.970	0.030
T38.4 Oral contraceptives	0.000	0.970	0.030
T38.2 Antithyroid drugs	0.000	0.970	0.030
T38.0 Glucocorticoids and synthetic analogues	0.000	0.970	0.030
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.030	0.970	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.970	0.030
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.970	0.030
T47.7 Emetics	0.000	0.970	0.030
T47.6 Antidiarrhoeal drugs	0.000	0.970	0.030
T47.5 Digestants	0.000	0.970	0.030
T47.3 Saline and osmotic laxatives	0.000	0.970	0.030
C91.8 Mature B-cell leukaemia Burkitt-type	0.030	0.970	0.000
C91.7 Other lymphoid leukaemia	0.030	0.970	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.030	0.970	0.000
C91.3 Prolymphocytic leukaemia	0.030	0.970	0.000
C91.2 Subacute lymphocytic leukaemia	0.030	0.970	0.000
C82.2 Large cell, follicular	0.030	0.970	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.030	0.970	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.030	0.970	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.030	0.970	0.000
C84.3 Lymphoepithelioid lymphoma	0.030	0.970	0.000
C84.2 T-zone lymphoma	0.030	0.970	0.000
C84.1 Sezary's diease	0.030	0.970	0.000
E05.9 Thyrotoxicosis, unspecified	0.029	0.971	0.000
T47.4 Other laxatives	0.000	0.971	0.029
T47.2 Stimulant laxatives	0.000	0.971	0.029
C83.3 Large cell (diffuse)	0.029	0.971	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.029	0.971	0.000
C94 Other leukaemias of specified cell type	0.029	0.971	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.971	0.028
C91.0 Acute lymphoblastic leukaemia	0.028	0.972	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.972	0.028
C93 Monocytic leukaemia	0.027	0.973	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.973	0.027
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.027	0.973	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.026	0.974	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.026	0.974	0.000
T47.0 Histamine H(2)-receptor antagonists	0.000	0.974	0.026
C90 Multiple myeloma and malignant plasma cell neoplasms	0.026	0.974	0.000
C82.0 Small cleaved cell, follicular	0.025	0.975	0.000
C91.4 Hairy-cell leukaemia	0.025	0.975	0.000
C83.0 Small cell (diffuse)	0.025	0.975	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.025	0.975	0.000
C81 Hodgkin's disease	0.025	0.975	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.976	0.024
C82.6 Cutaneous follicle centre lymphoma	0.024	0.976	0.000
C82.5 Diffuse follicle centre lymphoma	0.024	0.976	0.000
C82.4 Follicular lymphoma grade IIIb	0.024	0.976	0.000
C83.1 Small cleaved cell (diffuse)	0.024	0.976	0.000
C82.3 Follicular lymphoma grade IIIa	0.024	0.976	0.000
C95.9 Leukaemia, unspecified	0.024	0.976	0.000
C95.7 Other leukaemia of unspecified cell type	0.023	0.977	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.023	0.977	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.023	0.977	0.000
K93 Disorders of other digestive organs in diseases classified elsewhere	0.023	0.977	0.000
C95.0 Acute leukaemia of unspecified cell type	0.023	0.977	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.023	0.977	0.000
C85.1 B-cell lymphoma, unspecified	0.023	0.977	0.000
C90.2 Plasmacytoma, extramedullary	0.023	0.977	0.000
C83.6 Undifferentiated (diffuse)	0.023	0.977	0.000
C83.5 Lymphoblastic (diffuse)	0.023	0.977	0.000
C83.4 Immunoblastic (diffuse)	0.023	0.977	0.000
C83.2 Mixed small and large cell (diffuse)	0.023	0.977	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.023	0.977	0.000
C86.4 Blastic NK-cell lymphoma	0.023	0.977	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.023	0.977	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.023	0.977	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.023	0.977	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.023	0.977	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.022	0.977	0.000
C88.7 Other malignant immunoproliferative diseases	0.022	0.977	0.000
C88.3 Immunoproliferative small intestinal disease	0.022	0.977	0.000
C88.2 Gamma heavy chain disease	0.022	0.977	0.000
C88.1 Alpha heavy chain disease	0.022	0.977	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.977	0.023
C83.7 Burkitt's tumour	0.022	0.978	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.022	0.978	0.000
C85.0 Lymphosarcoma	0.022	0.978	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.978	0.022
E05 Thyrotoxicosis [hyperthyroidism]	0.021	0.979	0.000
C81.2 Mixed cellularity	0.021	0.979	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.021	0.979	0.000
C94.7 Other specified leukaemias	0.021	0.979	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.021	0.979	0.000
C94.5 Acute myelofibrosis	0.021	0.979	0.000
C94.4 Acute panmyelosis	0.021	0.979	0.000
C94.3 Mast cell leukaemia	0.021	0.979	0.000
C94.2 Acute megakaryoblastic leukaemia	0.021	0.979	0.000
C94.1 Chronic erythraemia	0.021	0.979	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.021	0.979	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.021	0.979	0.000
C96.8 Histiocytic sarcoma	0.021	0.979	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.021	0.979	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.021	0.979	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.021	0.979	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.021	0.979	0.000
C96.3 True histiocytic lymphoma	0.021	0.979	0.000
C96.2 Malignant mast cell tumour	0.021	0.979	0.000
C96.1 Malignant histiocytosis	0.021	0.979	0.000
C96.0 Letterer-Siwe disease	0.021	0.979	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.020	0.980	0.000
C93.9 Monocytic leukaemia, unspecified	0.020	0.980	0.000
C93.7 Other monocytic leukaemia	0.020	0.980	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.020	0.980	0.000
C93.2 Subacute monocytic leukaemia	0.020	0.980	0.000
C93.0 Acute monocytic leukaemia	0.020	0.980	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.980	0.020
E03.9 Hypothyroidism, unspecified	0.020	0.980	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.981	0.019
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.981	0.019
T43.6 Psychostimulants with abuse potential	0.000	0.981	0.019
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.018	0.982	0.000
C81.3 Lymphocytic depletion	0.018	0.982	0.000
E16.2 Hypoglycaemia, unspecified	0.018	0.982	0.000
C81.7 Other Hodgkin's disease	0.018	0.982	0.000
C93.1 Chronic monocytic leukaemia	0.018	0.982	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.018	0.982	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.982	0.017
C90.1 Plasma cell leukaemia	0.017	0.982	0.000
C81.9 Hodgkin's disease, unspecified	0.017	0.983	0.000
C92 Myeloid leukaemia	0.017	0.983	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.017	0.983	0.000
K93.8 Disorders of other specified digestive organs in diseases classified elsewhere	0.017	0.983	0.000
K93.1 Megacolon in Chagas' disease	0.017	0.983	0.000
K93.0 Tuberculous disorders of intestines, peritoneum and mesenteric glands	0.017	0.983	0.000
C90.3 Solitary plasmacytoma	0.017	0.983	0.000
E16 Other disorders of pancreatic internal secretion	0.017	0.983	0.000
T43.2 Other and unspecified antidepressants	0.000	0.983	0.017
E05.0 Thyrotoxicosis with diffuse goitre	0.017	0.983	0.000
E03 Other hypothyroidism	0.017	0.983	0.000
C81.0 Lymphocytic predominance	0.016	0.984	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.984	0.016
R20.2 Paraesthesia of skin	0.016	0.984	0.000
E00-E07 Disorders of thyroid gland	0.016	0.984	0.000
E05.5 Thyroid crisis or storm	0.015	0.984	0.000
E05.4 Thyrotoxicosis factitia	0.015	0.984	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.015	0.984	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.015	0.984	0.000
E05.8 Other thyrotoxicosis	0.015	0.985	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.015	0.985	0.000
E83.5 Disorders of calcium metabolism	0.000	0.985	0.015
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.015	0.985	0.000
O82 Single delivery by Caesarean section	0.000	0.985	0.015
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.014	0.986	0.000
C92.1 Chronic myeloid leukaemia	0.014	0.986	0.000
C92.9 Myeloid leukaemia, unspecified	0.014	0.986	0.000
E27.1 Primary adrenocortical insufficiency	0.014	0.986	0.000
E27 Other disorders of adrenal gland	0.014	0.986	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.014	0.986	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.014	0.986	0.000
E20-E35 Disorders of other endocrine glands	0.014	0.986	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.987	0.013
E16.1 Other hypoglycaemia	0.013	0.987	0.000
C81.1 Nodular sclerosis	0.013	0.987	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.013	0.987	0.000
E10.3 With ophthalmic complications	0.013	0.987	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.013	0.987	0.000
R31 Unspecified haematuria	0.000	0.987	0.013
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.012	0.987	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.012	0.987	0.000
C92.5 Acute myelomonocytic leukaemia	0.012	0.987	0.000
C92.3 Myeloid sarcoma	0.012	0.987	0.000
C92.2 Subacute myeloid leukaemia	0.012	0.987	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.013	0.987	0.000
F06.7 Mild cognitive disorder	0.000	0.987	0.013
E10 Insulin-dependent diabetes mellitus	0.013	0.987	0.000
E10.1 With ketoacidosis	0.012	0.988	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.012	0.988	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.012	0.988	0.000
E16.4 Abnormal secretion of gastrin	0.012	0.988	0.000
E16.3 Increased secretion of glucagon	0.012	0.988	0.000
E10-E14 Diabetes mellitus	0.012	0.988	0.000
E03.5 Myxoedema coma	0.012	0.988	0.000
E03.4 Atrophy of thyroid (acquired)	0.012	0.988	0.000
E03.3 Postinfectious hypothyroidism	0.012	0.988	0.000
E03.1 Congenital hypothyroidism without goitre	0.012	0.988	0.000
E25 Adrenogenital disorders	0.012	0.988	0.000
E29 Testicular dysfunction	0.012	0.988	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.011	0.988	0.000
E00 Congenital iodine-deficiency syndrome	0.011	0.988	0.000
C90.0 Multiple myeloma	0.011	0.989	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.011	0.989	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.011	0.989	0.000
O82.9 Delivery by Caesarean section, unspecified	0.000	0.989	0.011
E20 Hypoparathyroidism	0.011	0.989	0.000
C92.7 Other myeloid leukaemia	0.011	0.989	0.000
E15 Nondiabetic hypoglycaemic coma	0.011	0.989	0.000
E31 Polyglandular dysfunction	0.011	0.989	0.000
O82.8 Other single delivery by Caesarean section	0.000	0.989	0.011
O82.2 Delivery by Caesarean hysterectomy	0.000	0.989	0.011
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.010	0.990	0.000
E85 Amyloidosis	0.000	0.990	0.010
E24 Cushing's syndrome	0.010	0.990	0.000
D86.9 Sarcoidosis, unspecified	0.010	0.990	0.000
E29.1 Testicular hypofunction	0.010	0.990	0.000
E85.9 Amyloidosis, unspecified	0.000	0.990	0.010
E27.2 Addisonian crisis	0.010	0.990	0.000
E27.5 Adrenomedullary hyperfunction	0.010	0.990	0.000
E27.0 Other adrenocortical overactivity	0.010	0.990	0.000
C92.4 Acute promyelocytic leukaemia	0.010	0.990	0.000
E07 Other disorders of thyroid	0.010	0.990	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.010	0.990	0.000
E32 Diseases of thymus	0.010	0.990	0.000
E30 Disorders of puberty, not elsewhere classified	0.010	0.990	0.000
E10.7 With multiple complications	0.010	0.990	0.000
E34 Other endocrine disorders	0.010	0.990	0.000
D86 Sarcoidosis	0.010	0.990	0.000
E85.4 Organ-limited amyloidosis	0.000	0.990	0.010
E22 Hyperfunction of pituitary gland	0.010	0.990	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.010	0.990	0.000
D69.4 Other primary thrombocytopenia	0.009	0.991	0.000
E10.5 With peripheral circulatory complications	0.009	0.991	0.000
E85.3 Secondary systemic amyloidosis	0.000	0.991	0.009
D69 Purpura and other haemorrhagic conditions	0.009	0.991	0.000
E23 Hypofunction and other disorders of pituitary gland	0.009	0.991	0.000
E10.2 With renal complications	0.009	0.991	0.000
E13 Other specified diabetes mellitus	0.009	0.991	0.000
D80-D89 Certain disorders involving the immune mechanism	0.009	0.991	0.000
D69.9 Haemorrhagic condition, unspecified	0.009	0.991	0.000
E20.9 Hypoparathyroidism, unspecified	0.009	0.991	0.000
E31.0 Autoimmune polyglandular failure	0.009	0.991	0.000
E12 Malnutrition-related diabetes mellitus	0.009	0.991	0.000
D86.8 Sarcoidosis of other and combined sites	0.009	0.991	0.000
E24.2 Drug-induced Cushing's syndrome	0.009	0.991	0.000
E50-E64 Other nutritional deficiencies	0.009	0.991	0.000
K91.0 Vomiting following gastro-intestinal surgery	0.009	0.991	0.000
E10.6 With other specified complications	0.009	0.991	0.000
E10.0 With coma	0.009	0.991	0.000
E40-E46 Malnutrition	0.009	0.991	0.000
K91.9 Postprocedural disorder of digestive system, unspecified	0.009	0.991	0.000
K91.3 Postoperative intestinal obstruction	0.009	0.991	0.000
E26 Hyperaldosteronism	0.009	0.991	0.000
O99.2 Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium	0.000	0.991	0.009
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium	0.000	0.991	0.009
E02 Subclinical iodine-deficiency hypothyroidism	0.008	0.991	0.000
E25.9 Adrenogenital disorder, unspecified	0.008	0.991	0.000
E25.8 Other adrenogenital disorders	0.008	0.991	0.000
D80 Immunodeficiency with predominantly antibody defects	0.009	0.991	0.000
E10.9 Without complications	0.009	0.991	0.000
E29.9 Testicular dysfunction, unspecified	0.008	0.991	0.000
E29.8 Other testicular dysfunction	0.008	0.991	0.000
E29.0 Testicular hyperfunction	0.008	0.991	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.008	0.991	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.008	0.991	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.008	0.991	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.008	0.991	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.008	0.991	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.008	0.991	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.008	0.991	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.008	0.991	0.000
I22.9 Subsequent myocardial infarction of unspecified site	0.000	0.991	0.009
E14 Unspecified diabetes mellitus	0.008	0.992	0.000
E24.0 Pituitary-dependent Cushing's disease	0.008	0.992	0.000
E70-E90 Metabolic disorders	0.000	0.992	0.008
E34.9 Endocrine disorder, unspecified	0.008	0.992	0.000
D69.6 Thrombocytopenia, unspecified	0.008	0.992	0.000
D83 Common variable immunodeficiency	0.008	0.992	0.000
E20.8 Other hypoparathyroidism	0.008	0.992	0.000
E20.1 Pseudohypoparathyroidism	0.008	0.992	0.000
E20.0 Idiopathic hypoparathyroidism	0.008	0.992	0.000
E31.9 Polyglandular dysfunction, unspecified	0.008	0.992	0.000
E31.8 Other polyglandular dysfunction	0.008	0.992	0.000
E31.1 Polyglandular hyperfunction	0.008	0.992	0.000
E10.8 With unspecified complications	0.008	0.992	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.008	0.992	0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium	0.000	0.992	0.008
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.008	0.992	0.000
R20 Disturbances of skin sensation	0.008	0.992	0.000
E27.8 Other specified disorders of adrenal gland	0.008	0.992	0.000
O99.7 Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium	0.000	0.992	0.008
O99.3 Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium	0.000	0.992	0.008
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.008	0.992	0.000
E23.2 Diabetes insipidus	0.008	0.992	0.000
E85.8 Other amyloidosis	0.000	0.992	0.008
E85.2 Heredofamilial amyloidosis, unspecified	0.000	0.992	0.008
E85.1 Neuropathic heredofamilial amyloidosis	0.000	0.992	0.008
E85.0 Nonneuropathic heredofamilial amyloidosis	0.000	0.992	0.008
E24.8 Other Cushing's syndrome	0.008	0.992	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.008	0.992	0.000
E24.3 Ectopic ACTH syndrome	0.008	0.992	0.000
E24.1 Nelson's syndrome	0.008	0.992	0.000
E14.1 With ketoacidosis	0.008	0.992	0.000
E07.8 Other specified disorders of thyroid	0.008	0.992	0.000
D84 Other immunodeficiencies	0.008	0.992	0.000
E23.7 Disorder of pituitary gland, unspecified	0.007	0.992	0.000
E34.3 Short stature, not elsewhere classified	0.007	0.992	0.000
R23.8 Other and unspecified skin changes	0.008	0.992	0.000
D83.9 Common variable immunodeficiency, unspecified	0.007	0.992	0.000
E14.5 With peripheral circulatory complications	0.007	0.992	0.000
E07.1 Dyshormogenetic goitre	0.007	0.993	0.000
E07.0 Hypersecretion of calcitonin	0.007	0.993	0.000
D86.3 Sarcoidosis of skin	0.007	0.993	0.000
E22.1 Hyperprolactinaemia	0.007	0.993	0.000
E55 Vitamin D deficiency	0.007	0.993	0.000
E30.9 Disorder of puberty, unspecified	0.007	0.993	0.000
E30.8 Other disorders of puberty	0.007	0.993	0.000
E30.1 Precocious puberty	0.007	0.993	0.000
E30.0 Delayed puberty	0.007	0.993	0.000
E32.9 Disease of thymus, unspecified	0.007	0.993	0.000
E32.8 Other diseases of thymus	0.007	0.993	0.000
E32.1 Abscess of thymus	0.007	0.993	0.000
E32.0 Persistent hyperplasia of thymus	0.007	0.993	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.007	0.993	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.007	0.993	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.007	0.993	0.000
O82.1 Delivery by emergency Caesarean section	0.000	0.993	0.007
E03.8 Other specified hypothyroidism	0.007	0.993	0.000
E34.5 Androgen resistance syndrome	0.007	0.993	0.000
E34.4 Constitutional tall stature	0.007	0.993	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.007	0.993	0.000
E34.1 Other hypersecretion of intestinal hormones	0.007	0.993	0.000
E27.9 Disorder of adrenal gland, unspecified	0.007	0.993	0.000
O99.6 Diseases of the digestive system complicating pregnancy, childbirth and the puerperium	0.000	0.993	0.007
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.007	0.993	0.000
R23.1 Pallor	0.007	0.993	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.993	0.007
E21.0 Primary hyperparathyroidism	0.007	0.993	0.000
E53 Deficiency of other B group vitamins	0.007	0.993	0.000
O99.5 Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium	0.000	0.993	0.007
E34.8 Other specified endocrine disorders	0.007	0.993	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.007	0.993	0.000
E22.8 Other hyperfunction of pituitary gland	0.007	0.993	0.000
E13.3 With ophthalmic complications	0.007	0.993	0.000
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.007	0.993	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.007	0.993	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.007	0.993	0.000
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.007	0.993	0.000
D69.2 Other nonthrombocytopenic purpura	0.007	0.993	0.000
D69.1 Qualitative platelet defects	0.007	0.993	0.000
E10.4 With neurological complications	0.007	0.993	0.000
K91.1 Postgastric surgery syndromes	0.007	0.993	0.000
D69.8 Other specified haemorrhagic conditions	0.007	0.993	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.007	0.993	0.000
E23.1 Drug-induced hypopituitarism	0.007	0.993	0.000
R20.1 Hypoaesthesia of skin	0.007	0.993	0.000
E13.8 With unspecified complications	0.007	0.993	0.000
E13.7 With multiple complications	0.007	0.993	0.000
E13.6 With other specified complications	0.007	0.993	0.000
E13.5 With peripheral circulatory complications	0.007	0.993	0.000
E13.4 With neurological complications	0.007	0.993	0.000
E13.2 With renal complications	0.007	0.993	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations